GMP – Page 99 – Pharma.Tips

Unapproved material substitution during supplier change – preventing batch rejection and recalls

Preventing Batch Rejection and Recalls Due to Unapproved Material Substitution In the complex world of pharmaceutical manufacturing, the unapproved substitution of raw materials during a supplier change can lead to…

Quality agreement gaps during supply disruption – audit CAPA remediation framework

Addressing Quality Agreement Discrepancies Amid Supply Chain Disruptions In pharmaceutical manufacturing, maintaining consistent quality throughout the supply chain is paramount. Disruptions can expose gaps in quality agreements with suppliers, potentially…

Change control documentation gaps during deviation investigation – risk-based change impact assessment

Addressing Change Control Documentation Gaps in Deviation Investigations: A Risk-Based Playbook Pharmaceutical manufacturing involves numerous complexities, and deviations can lead to significant operational setbacks. A critical aspect of robust deviation…

Vendor change implemented without approval during requalification – inspection questions regulators ask

Investigating Unapproved Vendor Changes During the Requalification Process in Pharmaceutical Manufacturing In the ever-evolving landscape of pharmaceutical manufacturing, maintaining robust quality systems is essential to ensure compliance and product integrity.…

Raw material change implemented without assessment during deviation investigation – risk-based change impact assessment

Managing Raw Material Changes Without Prior Assessment During Deviations: An Effective Playbook The pharmaceutical industry faces a multitude of challenges regarding raw material management, particularly when material changes occur without…

Inadequate vendor qualification during routine supplier audit – audit CAPA remediation framework

Framework for Addressing Inadequate Vendor Qualification During Routine Supplier Audits In the highly regulated pharmaceutical environment, inadequate vendor qualification can lead to significant risks in product quality and compliance. This…

Unapproved material substitution during post-approval change review – risk-based change impact assessment

Managing Risks of Unapproved Material Substitution in Post-Approval Changes Unapproved material substitutions during post-approval change reviews pose significant risks in pharmaceutical manufacturing. They can lead to quality deviations, regulatory non-compliance,…

Quality agreement gaps during supplier onboarding – how to prevent repeat supplier failures

Preventing Recurrent Failures Linked to Quality Agreement Gaps in Supplier Onboarding In an increasingly complex pharmaceutical landscape, the integrity of raw materials and compliance with Good Manufacturing Practices (GMP) hinge…

Supplier change not evaluated during deviation investigation – CAPA to prevent repeat failures

Effective Strategies for Evaluating Supplier Changes During Deviation Investigations Changes in suppliers of raw materials can significantly impact the quality and safety of pharmaceutical products. When these changes are not…

Inadequate vendor qualification during requalification – inspection questions regulators ask

Investigating Issues with Vendor Qualification During Requalification In the pursuit of maintaining product quality, pharmaceutical manufacturers often face challenges arising from inadequate vendor qualification, particularly during the requalification process. Regulatory…

Specification change not communicated during routine operations – CAPA to prevent repeat failures

Addressing Uncommunicated Specification Changes during Routine Operations: A Comprehensive CAPA Playbook Specification changes that go uncommunicated during manufacturing operations can lead to significant quality issues, regulatory concerns, and increased operational…

Audit response ineffective during supplier onboarding – audit CAPA remediation framework

Addressing Ineffective Audit Responses During Supplier Onboarding: A Framework for Remediation In the pharmaceutical industry, the integrity of supplier onboarding processes is critical to maintaining compliance and ensuring the quality…